Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Refugees | 3 | 2019 | 10 | 0.870 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 242 | 0.620 |
Why?
|
| Diabetes, Gestational | 2 | 2010 | 28 | 0.600 |
Why?
|
| Obstetrics | 1 | 2019 | 25 | 0.590 |
Why?
|
| Islam | 1 | 2019 | 2 | 0.580 |
Why?
|
| Arabs | 1 | 2019 | 4 | 0.580 |
Why?
|
| Maternal Health Services | 1 | 2019 | 5 | 0.580 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 9 | 0.540 |
Why?
|
| Autoimmune Diseases | 1 | 2017 | 46 | 0.530 |
Why?
|
| Clinical Competence | 1 | 2019 | 329 | 0.500 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 317 | 0.490 |
Why?
|
| Primary Health Care | 1 | 2017 | 232 | 0.450 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2013 | 23 | 0.380 |
Why?
|
| Patient Selection | 1 | 2010 | 272 | 0.290 |
Why?
|
| Pregnancy | 3 | 2019 | 963 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 390 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1436 | 0.210 |
Why?
|
| T-Lymphocytes | 5 | 2003 | 138 | 0.200 |
Why?
|
| Hypertension | 1 | 2009 | 983 | 0.180 |
Why?
|
| Humans | 8 | 2019 | 32284 | 0.170 |
Why?
|
| Serbia | 1 | 2019 | 4 | 0.150 |
Why?
|
| Foreign Medical Graduates | 1 | 2019 | 4 | 0.150 |
Why?
|
| Female | 6 | 2019 | 19954 | 0.150 |
Why?
|
| Community Networks | 1 | 2019 | 22 | 0.140 |
Why?
|
| North Carolina | 2 | 2019 | 1299 | 0.140 |
Why?
|
| Spleen | 4 | 2003 | 82 | 0.140 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 75 | 0.140 |
Why?
|
| Drugs, Generic | 1 | 2017 | 14 | 0.130 |
Why?
|
| Drug Approval | 1 | 2017 | 13 | 0.130 |
Why?
|
| Drug Costs | 1 | 2017 | 46 | 0.130 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 198 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2017 | 411 | 0.120 |
Why?
|
| Burns | 3 | 2001 | 101 | 0.120 |
Why?
|
| Adult | 3 | 2019 | 9263 | 0.110 |
Why?
|
| Escherichia coli Infections | 3 | 2003 | 59 | 0.100 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 47 | 0.090 |
Why?
|
| United States | 2 | 2019 | 4079 | 0.090 |
Why?
|
| Risk Factors | 2 | 2010 | 3938 | 0.090 |
Why?
|
| Animals | 6 | 2017 | 8165 | 0.080 |
Why?
|
| Sepsis | 2 | 2001 | 163 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 212 | 0.070 |
Why?
|
| Child | 2 | 2019 | 2446 | 0.070 |
Why?
|
| Male | 6 | 2019 | 19434 | 0.070 |
Why?
|
| Dinoprostone | 3 | 2003 | 31 | 0.070 |
Why?
|
| Interleukin-2 | 3 | 2003 | 38 | 0.060 |
Why?
|
| Mass Screening | 1 | 2009 | 256 | 0.060 |
Why?
|
| Bacteroides Infections | 2 | 2003 | 3 | 0.060 |
Why?
|
| Age Factors | 1 | 2009 | 1179 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2003 | 137 | 0.050 |
Why?
|
| Bacteroides fragilis | 1 | 2003 | 1 | 0.050 |
Why?
|
| Peyer's Patches | 1 | 2001 | 1 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 2001 | 8 | 0.040 |
Why?
|
| Intestines | 1 | 2001 | 66 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 2000 | 63 | 0.040 |
Why?
|
| Licensure, Medical | 1 | 2019 | 5 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2003 | 896 | 0.040 |
Why?
|
| Medical Audit | 1 | 2019 | 15 | 0.040 |
Why?
|
| Calcium | 1 | 2001 | 337 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 83 | 0.030 |
Why?
|
| Ethanol | 1 | 2000 | 195 | 0.030 |
Why?
|
| Nitrobenzenes | 3 | 2003 | 9 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 2003 | 38 | 0.030 |
Why?
|
| Rats | 4 | 2003 | 1892 | 0.030 |
Why?
|
| Physicians | 1 | 2019 | 163 | 0.030 |
Why?
|
| Sulfonamides | 3 | 2003 | 85 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2001 | 716 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2019 | 317 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 2652 | 0.020 |
Why?
|
| Concanavalin A | 2 | 2001 | 3 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 3521 | 0.020 |
Why?
|
| Cell Division | 1 | 2003 | 91 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2003 | 56 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2001 | 1 | 0.010 |
Why?
|
| Indomethacin | 1 | 2001 | 7 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 128 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2001 | 66 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2001 | 49 | 0.010 |
Why?
|
| Random Allocation | 1 | 2001 | 246 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 83 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2001 | 17 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2001 | 23 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2001 | 248 | 0.010 |
Why?
|
| Stilbenes | 1 | 2001 | 18 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 31 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2001 | 114 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2001 | 67 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2001 | 51 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 470 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2003 | 484 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 21 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 94 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2001 | 243 | 0.010 |
Why?
|
| Apoptosis | 1 | 2000 | 367 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2000 | 776 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2000 | 256 | 0.010 |
Why?
|
| Mice | 1 | 2000 | 2544 | 0.010 |
Why?
|